Renaldee is bringing the first natural active form of Vit. D (1,25-dihydroxyvitamin D3) into a human pharma market extracted entirely from a plant, solanum glaucophyllum. Our offering is not to be confused with the inactive form of Vit. D which you can buy over the counter.
Products, services, technology
Our main product, Solrena®, is a purified and standardized plant extract containing 1,25-Dihydroxyvitamin D3-glycosides, the active form of vitamin D in unique glycoform, under development as prescription drug. This product is important in chronic kidney disease (CKD) and osteoporosis.
Cooperation possibilities
We are mainly looking for investors and commercialisation partners.
- https://renaldee.com
- +41 76 383 49 40
- contact@renaldee.com
- Anna Grabowski
Some insights
It is no secret that many natural products are better for the patient than current synthetic offerings. Solrena® will be no exception. We expect a better pharmacokinetic profile and therefore a better tolerance.
The solutions to the current health care crisis with ageing populations & exploding costs will come from many directions. We believe to make a contribution to solving this crisis by offering a natural alternative to what is currently done only in chemical synthesis while better serving the patient.
We have a wonderful team with an impressive entrepreneurial track record. Where we need help is commercialisation in a human pharma market.
We are happy to be part of this impressive network and hope to be in touch with potential partners for further growth.
We look forward to meeting investors and potential commercialisation partners.